The expression of interleukin‐15 and interleukin‐17 in tears and orbital tissues of Graves ophthalmopathy patients
Author:
- 19 December 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (4) , 6299-6303
Abstract
Objective: The objective of this study was to study the levels of interleukin (IL)‐15 and IL‐17 in tears and orbital tissues of the patients with the Graves ophthalmopathy (GO) (active and inactive stages) and in controls.Methods: Twenty‐four active GO patients (CAS ≥ 3/7) were collected in our research. All patients were treated with corticosteroids during the therapy process (4‐15 months) and developed into the inactive phase (CAS ≤ 2/7). The tear samples were gathered from inactive and active stages of patients with GO and sex‐matched and age‐matched controls (volunteers, n = 24) for the enzyme‐linked immunosorbent assay measurement of IL‐15 and IL‐17. The orbital tissues were collected from inactive stage of patients with GO and healthy volunteers for the analysis of IL‐15 and IL‐17 positive cells using the immunohistochemical analysis.Results: In comparison with the volunteers, significant upregulation of IL‐15 and IL‐17 were identified in tears of active (P < 0.05) and inactive patients with GO ( P < 0.01). Compared with inactive patients with GO, the levels of IL‐15 and IL‐17 in the tears were obviously higher than those in the active patients with GO. In addition, higher expression of IL‐15 and IL‐17 positive cells were found in the orbital organization of inactive patients with GO compared with volunteers.Conclusion: The differences in IL‐15 and IL‐17 expression between GO patients (active and inactive stages) and controls suggested both IL‐15 and IL‐17 expression were significantly correlated with thyroid‐associated ophthalmopathy pathogenesis and development.Keywords
This publication has 17 references indexed in Scilit:
- IL‐15: a central regulator of celiac disease immunopathologyImmunological Reviews, 2014
- IL-17 cytokines in immunity and inflammationEmerging Microbes & Infections, 2013
- The role of the IL-23/IL-17 axis in the pathogenesis of Graves’ diseaseEndocrine Journal, 2013
- Interleukin-7 expression in tears and orbital tissues of patients with Graves’ ophthalmopathyEndocrine, 2012
- Interleukin 18 and transforming growth factor β1 in the serum of patients with Graves' ophthalmopathy treated with corticosteroidsInternational Immunopharmacology, 2003
- Interleukin (IL)-15 and IL-7 Jointly Regulate Homeostatic Proliferation of Memory Phenotype CD8+ Cells but Are Not Required for Memory Phenotype CD4+ CellsJournal of Experimental Medicine, 2002
- Management of Graves' Ophthalmopathy: Reality and PerspectivesEndocrine Reviews, 2000
- Diagnostic Criteria for Graves' OphthalmopathyAmerican Journal of Ophthalmology, 1995
- Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts.Journal of Clinical Investigation, 1994
- Pathogenesis of Graves' OphthalmopathyNew England Journal of Medicine, 1993